Navigation Links
Conference to set the research agenda on Vitamin D in health and disease
Date:3/29/2010

An important conference on the actions of Vitamin D on human health is being hosted by Barts and The London Medical School and the MRC Asthma UK Centre in Allergic Mechanisms of Asthma.

Vitamin D has been known for some time to be important for healthy bones, now new research suggests it has possible benefits in other aspects of health including immune function, tuberculosis, asthma, diabetes, multiple sclerosis, gut function, skin, and the prostate, all of which will be addressed at the one-day event, being held on Tuesday 30 March at the Centre for Health Sciences in Whitechapel, London.

Attended by expert researchers from around the world the conference aims to stimulate debate, advance understanding, and set the research agenda in this exciting and increasingly topical field.

The programme is as follows:

Session 1 Epidemiology and Diabetes

10.15am Dr Elina Hyppnen
University College London
Vitamin D in health and disease insights from epidemiology

10.45am Professor Chantal Mathieu
Laboratory for Experimental Medicine and Endocrinology, Katholieke Universiteit Leuven, Belgium
Vitamin D and type 1 diabetes mellitus

11.15am Dr Barbara Boucher
Barts and The London School of Medicine and Dentistry
Vitamin D and type 2 diabetes

Session 2 Immunomodulatory actions of Vitamin D

12.00pm Dr Jrgen Schauber
University of Munich, Germany
Vitamin D and the cutaneous innate immune system

12.30pm Professor Margherita Cantorna
Pennsylvania State University, USA
Vitamin D and autoimmune disease

1.00pm Professor Kasia Hawrylowicz
King's College London
Vitamin D, regulatory T cells and allergic disease

Session 3: Clinical aspects 1: prostate and gut

2.15pm Dr Luciano Adorini
Chief Scientific Officer
Intercept Pharma, Italy
Vitamin D receptor agonists in the treatment of inflammatory prostatic disease

2.45pm Dr Julian Walters
Imperial College, London
Vitamin D and the gut

Session 4 Clinical aspects 2: tuberculosis and multiple sclerosis

3.30pm Dr Adrian Martineau
Barts and The London School of Medicine and Dentistry
Vitamin D and tuberculosis

4.30pm Professor George Ebers
Oxford University
Vitamin D and multiple sclerosis

The event will be chaired by Professor Chris Griffiths of the Centre for Health Sciences at Barts and The London Medical School.


'/>"/>

Contact: Alex Fernandes
a.fernandes@qmul.ac.uk
020-788-27910
Queen Mary, University of London
Source:Eurekalert

Related biology news :

1. Office of the Director of National Intelligence, CIO to Speak at Government Security Conference
2. Director of National Intelligence to Speak at Conference
3. Last chance for media to register for ECCO 14 -- the European Cancer Conference
4. Iowa State University conference examines developing bioeconomy
5. Minister Lunn to attend Union of BC Municipalities Pine Beetle Conference
6. Conference to examine role technology can play in helping US manage healthcare costs
7. Office of the Director of National Intelligence, CIO to Speak at Government Security Conference
8. Director of National Intelligence to Speak at Conference
9. Cardiologists and heart surgeons meet for Controversies and Advances conference
10. Conference on sustainable transportation is Oct. 29-31
11. UD hosts conference on knowledge-based partnerships Nov. 2
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/6/2017)... , Jan. 6, 2017  Privately-held CalciMedica, Inc., ... in healthy volunteers of a novel calcium release-activated ... acute pancreatitis. Acute pancreatitis, sudden ... mild disorder, but can be very serious.  In severe ... sepsis, where extended hospital stays, time in the ...
(Date:1/3/2017)... VEGAS , Jan. 3, 2017 Onitor, ... the introduction of Onitor Track, an innovative biometric data-driven ... men, showcasing this month at the 2017 Consumer Electronics ... In the U.S., the World Health ... more than two-thirds of adults who are overweight or ...
(Date:12/19/2016)... BARCELONA , España y TORONTO , 19 ... fusión con Northern Biologics Inc. que permitirá el desarrollo acelerado de ... ensayos clínicos en varios tipos de tumor en 2017, con múltiples ... ... de su clase con objetivo en el factor inhibidor de leucemia ...
Breaking Biology News(10 mins):
(Date:1/20/2017)... ... January 20, 2017 , ... ... Surgery (LES®) Technologies, announced today the next evolution in spinal fusion, the ... platform). In contrast to the competition, SpineFrontier is focused on technique driven ...
(Date:1/19/2017)... 19, 2017 /PRNewswire -- WuXi AppTec, a leading ... and technology platform, today announced that it has ... preclinical drug discovery contract research organization (CRO). After ... wholly-owned subsidiary of WuXi, and will continue to ... greater services. The acquisition will further strengthen WuXi,s ...
(Date:1/19/2017)... and GAITHERSBURG, Md. , Jan. ... and Altimmune, Inc., a privately-held immunotherapeutics company targeting ... definitive agreement for the merger of PharmAthene and ... include Novartis Venture Fund, HealthCap, Truffle Capital and ... fully-integrated and diversified immunotherapeutics company with four clinical ...
(Date:1/19/2017)... ... 18, 2017 , ... LabRoots , the leading provider ... world, was today awarded the "Best Science & Technology Social Networking Service 2016" ... decided upon by a dedicated team of researchers and analysts. , The 2016 ...
Breaking Biology Technology: